当前位置: 首页 > 期刊 > 《茶·健康天地》 > 2015年第12期
编号:12711079
凝血酶原复合物在儿童血友病预防治疗中的应用(2)
http://www.100md.com 2015年12月1日 《饮食与健康·下旬刊》 2015年第12期
     [1]Coppola A,Franchini M,Tagliaferri A.Prophylaxis in people with haemophilia.Thromb Haemost,2009,101:674-681.5White GC,Rosendaal F,Aledort LM,et a1.Definitions in hemophilia.Recommendation of the scientific subcommittee on factor Ⅷand factor D of the scientific and standardization committee of the Intcmational Society on Thrombosis and Haemostasis[J].Thromb Haemost,2001,85.

    [2]Naraine VS,Risebmugll NA,Oh P,et a1.Health—related quality—of-life treatments for severe haemophiha:utility measurements using the Stan—dard Gambletechnique[j].Haemophilia,2002,8(2):112—120.

    [3] Steen CK,Hojgard S,Glomstein A,et a1.On demand VS.pmphy—lactic trentment for severe hemophilia in Norway and Sweden.Haemophila,2003,9:555-66.

    [4]Naraine VS,Risebmugll NA,Oh P,et a1.Health—related quality—of-life treatments for severe haemophiha:utility measurements using the Stan—dard Gambletechnique[j].Haemophilia,2002,8(2):112—120.

    [5]儿童血友病预防治疗及其剂量选择.唐凌吴润晖. 中华儿科杂志,2012年1月50卷第一期,Vol 50 NO 1.

    [6]吴润晖,胡群.儿童血友病诊疗建议.中华儿科杂志,2011,49;193—196.

    [7].唐凌,吴润晖.儿童血友病预防治疗及其剂量选择[J].中华儿科杂志,2012,50(1):70一73., http://www.100md.com(王金乐)
上一页1 2